Joachim Dissemond Selected Research

Melanoma (Melanoma, Malignant)

7/2015	Intraoperative Fluorescence Imaging for Sentinel Lymph Node Detection: Prospective Clinical Trial to Compare the Usefulness of Indocyanine Green vs Technetium Tc 99m for Identification of Sentinel Lymph Nodes.
4/2010	Sentinel lymph node excision and PET-CT in the initial stage of malignant melanoma: a retrospective analysis of 61 patients with malignant melanoma in American Joint Committee on Cancer stages I and II.
9/2009	[Malignant melanoma masquerading as a neurotrophic ulcer].
1/2004	Differential downregulation of endoplasmic reticulum-residing chaperones calnexin and calreticulin in human metastatic melanoma.
10/2003	Activated neutrophils exert antitumor activity against human melanoma cells: reactive oxygen species-induced mechanisms and their modulation by granulocyte-macrophage-colony-stimulating factor.
8/2003	Immunoproteasome subunits LMP2 and LMP7 downregulation in primary malignant melanoma lesions: association with lack of spontaneous regression.
6/2003	Association of TAP1 downregulation in human primary melanoma lesions with lack of spontaneous regression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joachim Dissemond Research Topics

Disease

51	Wounds and Injuries (Trauma) 04/2024 - 09/2004
22	Leg Ulcer 10/2023 - 01/2003
11	Infections 12/2023 - 10/2004
9	Pain (Aches) 02/2024 - 10/2015
9	Ulcer 12/2023 - 02/2006
7	Edema (Dropsy) 02/2024 - 06/2018
7	Pyoderma Gangrenosum 02/2024 - 04/2015
7	Neoplasms (Cancer) 04/2019 - 01/2004
7	Melanoma (Melanoma, Malignant) 07/2015 - 06/2003
5	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2024 - 09/2006
3	Skin Diseases (Skin Disease) 02/2024 - 01/2021
3	Necrosis 09/2023 - 09/2004
3	Venous Insufficiency 05/2021 - 08/2006
3	Inflammation (Inflammations) 10/2020 - 06/2017
2	Lymphatic Diseases 02/2024 - 06/2018
2	Necrobiosis Lipoidica 02/2024 - 07/2018
2	Erysipelas 02/2024 - 01/2021
2	Livedoid Vasculopathy 02/2024 - 07/2018
2	Autoimmune Diseases (Autoimmune Disease) 11/2023 - 09/2006
2	Pressure Ulcer (Bedsore) 10/2023 - 06/2017
2	Peripheral Arterial Disease 01/2023 - 07/2018
2	Burns 10/2022 - 01/2018
2	Foreign Bodies (Foreign Body) 05/2022 - 09/2004
2	Diabetic Foot 01/2022 - 06/2017
2	Obesity 02/2021 - 06/2018
2	Surgical Wound 12/2020 - 06/2017
2	Wound Infection (Wound Infections) 12/2020 - 03/2015
2	Varicose Ulcer (Ulcer, Venous) 08/2020 - 06/2016
2	Renal Cell Carcinoma (Grawitz Tumor) 10/2016 - 08/2003
2	Psoriatic Arthritis 11/2008 - 01/2005
2	HIV Infections (HIV Infection) 09/2007 - 10/2004
2	Spontaneous Remission 08/2003 - 06/2003
1	Vascular Skin Diseases 02/2024
1	Hypersensitivity (Allergy) 11/2023
1	Mental Disorders (Mental Disorder) 11/2023
1	Foot Ulcer 10/2023
1	Eczema 10/2023
1	Hyperglycemia 01/2023
1	Heart Failure 01/2023
1	Angioedema 01/2023
1	Postthrombotic Syndrome 01/2023
1	Localized Scleroderma (Morphea) 01/2023
1	Chemical Burns (Chemical Burn) 10/2022
1	Blister (Bulla) 10/2022
1	Varicose Veins (Varicose Vein) 07/2022
1	COVID-19 05/2022
1	Diabetes Complications 01/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2021

Drug/Important Bio-Agent (IBA)

8	Local Anti-Infective Agents (Antiseptics)IBA 02/2023 - 12/2010
4	polihexanideIBA 02/2023 - 07/2014
4	SilverIBA 05/2022 - 05/2017
3	Anti-Bacterial Agents (Antibiotics)IBA 04/2020 - 04/2005
3	Peptides (Polypeptides)IBA 01/2004 - 06/2003
2	GlucocorticoidsIBA 10/2023 - 01/2023
2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 09/2007
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022 - 12/2018
2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2020 - 01/2019
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2020 - 01/2019
2	SolutionsIBA 01/2019 - 01/2018
2	octenidineIBA 01/2019 - 07/2014
2	SiliconesIBA 12/2015 - 05/2006
2	Hydroxyurea (Hydrea)FDA LinkGeneric 05/2009 - 02/2006
2	EpitopesIBA 01/2004 - 08/2003
1	Hematoxylin (Haematoxylon)IBA 12/2023
1	Eosine Yellowish-(YS) (Eosin)IBA 12/2023
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 11/2023
1	Carboxymethylcellulose Sodium (Polycell)FDA Link 10/2023
1	Complement System Proteins (Complement)IBA 09/2023
1	Interleukin-17 (Interleukin 17)IBA 09/2023
1	Interleukin-23 (Interleukin 23)IBA 09/2023
1	Interleukin-1 (Interleukin 1)IBA 09/2023
1	SteroidsIBA 01/2023
1	pimecrolimus (Elidel)FDA Link 01/2023
1	Estrogens (Estrogen)FDA Link 01/2023
1	Omalizumab (Xolair)FDA Link 01/2023
1	Polychlorinated Biphenyls (PCBs)IBA 12/2022
1	Aligeron (AS 2)IBA 01/2022
1	Immunomodulating AgentsIBA 01/2022
1	Methicillin (Metin)FDA Link 12/2020

Therapy/Procedure

59	Therapeutics 04/2024 - 06/2004
5	Debridement 04/2024 - 09/2004
4	Contraindications 08/2023 - 06/2018
3	Negative-Pressure Wound Therapy 01/2019 - 06/2017
2	Punctures 10/2022 - 01/2018
2	Surgical Amputation (Amputations) 01/2022 - 10/2004
2	Skin Transplantation (Skin Grafting) 02/2021 - 04/2018
2	Compression Bandages 01/2019 - 05/2017
2	Compression Stockings 11/2016 - 09/2016
2	Lasers (Laser) 12/2015 - 09/2004
1	Off-Label Use 02/2024
1	Biological Therapy 09/2023
1	Conservative Treatment 01/2023
1	Bandages (Bandage) 09/2022
1	Catheters 07/2022
1	Magnetic Field Therapy 06/2022
1	Ligation 02/2021
1	Transplantation 02/2021
1	Fasciotomy 02/2021
1	Skin Care 01/2021
1	Analgesia 01/2021